
Phil Mickelson and three other LIV golfers have dropped out of an antitrust lawsuit against the PGA Tour.
Mickelson and 10 other LIV-affiliated players had filed a suit against the PGA Tour in August after the tour suspended them for their participation in the rival LIV Golf league. The suit alleged that the PGA Tour’s suspensions were anticompetitive.
Jonathan Grella, an LIV Golf representative, said the merits of the suit still stand and that the LIV will continue to pursue the case.
Talor Gooch, Hudson Swafford and Ian Poulter also dismissed their claims against the PGA Tour, according to a court filing Tuesday with the U.S. District Court for the Northern District of California.
“With LIV’s involvement in these issues, the players’ rights will be protected, and I no longer feel it is necessary for me to be part of the proceedings,” Mickelson said in a statement provided through LIV Golf.
The three other players also signaled their confidence that LIV was adequately pursuing the antitrust claims. The Justice Department is also probing into the PGA Tour for its possible antitrust violations tied to LIV Golf.
When the lawsuit was initially filed, PGA Tour commissioner Jay Monahan stood by the decision to suspend the LIV-affiliated players.
“To allow reentry into our events compromises the TOUR and the competition, to the detriment of our organization, our players, our partners and our fans,” Monahan wrote in a memo to tour members.
LIV Golf has also been subject of scrutiny. The league is funded in part by the Saudi Arabia Public Investment Fund, which is controlled by the Crown Prince of Saudi Arabia.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas